Escalera Merino deepened her understanding on the role of mutations in the SARS-CoV-2 spike protein during her training on effector function assays in Dr. Taia Wang’s lab.
Wiggins visited Dr. Andrea Sant’s lab to deepen her understanding of CD4+ T-cell responses to a COBRA-designed influenza vaccine candidate administered to obese mouse models.
NIAID hosted the 2024 CIVICs Annual Network Meeting (ANM) from August 4-7 in Bethesda, Maryland for nearly 370 virtual and in-person attendees. The meeting featured engaging discussion and presentations from recent scientific achievements across CIVICs. The meeting concluded with the first-ever CIVICs industry day.